Invention Grant
US08222227B2 RNAi-mediated inhibition of histamine receptor H1-related conditions
有权
RNAi介导的组胺受体H1相关病症的抑制
- Patent Title: RNAi-mediated inhibition of histamine receptor H1-related conditions
- Patent Title (中): RNAi介导的组胺受体H1相关病症的抑制
-
Application No.: US13173512Application Date: 2011-06-30
-
Publication No.: US08222227B2Publication Date: 2012-07-17
- Inventor: John M. Yanni , Jon E. Chatterton , Daniel A. Gamache , Steven T. Miller
- Applicant: John M. Yanni , Jon E. Chatterton , Daniel A. Gamache , Steven T. Miller
- Applicant Address: US TX Fort Worth
- Assignee: Alcon Research, Ltd.
- Current Assignee: Alcon Research, Ltd.
- Current Assignee Address: US TX Fort Worth
- Agent Jason J. Derry
- Main IPC: C12N15/11
- IPC: C12N15/11
Abstract:
RNA interference is provided for inhibition of histamine receptor H1 mRNA expression, in particular, for treating patients having an HRH1-related condition or at risk of developing an HRH1-related condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, or allergy.
Public/Granted literature
- US20110269822A1 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions Public/Granted day:2011-11-03
Information query
IPC分类:
